Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance

被引：66

作者：

Pech, Matthew ^{[1
]}

Fong, Linda E. ^{[1
]}

Villalta, Jacqueline E. ^{[1
]}

Chan, Leanne J. G. ^{[1
]}

Kharbanda, Samir ^{[1
]}

O'Brien, Jonathon J. ^{[1
]}

McAllister, Fiona E. ^{[1
]}

Firestone, Ari J. ^{[1
]}

Jan, Calvin H. ^{[1
]}

Settleman, Jeffrey ^{[1
]}

机构：

[1] Cal Life Sci LLC, San Francisco, CA 94080 USA

来源：

ELIFE | 2019年 / 8卷

关键词：

NK CELLS; SELECTIVE DEGRADATION; GENE-EXPRESSION; CO-STIMULATION; PD-1; BLOCKADE; TUMOR-CELLS; QUANTIFICATION; IMMUNOTHERAPY; RESISTANCE; PROTEOMICS;

D O I：

10.7554/eLife.47362

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Only a subset of cancer patients respond to T-cell checkpoint inhibitors, highlighting the need for alternative immunotherapeutics. We performed CRISPR-Cas9 screens in a leukemia cell line to identify perturbations that enhance natural killer effector functions. Our screens defined critical components of the tumor-immune synapse and highlighted the importance of cancer cell interferon-gamma signaling in modulating NK activity. Surprisingly, disrupting the ubiquitin ligase substrate adaptor DCAF15 strongly sensitized cancer cells to NK-mediated clearance. DCAF15 disruption induced an inflamed state in leukemic cells, including increased expression of lymphocyte costimulatory molecules. Proteomic and biochemical analysis revealed that cohesin complex members were endogenous client substrates of DCAF15. Genetic disruption of DCAF15 was phenocopied by treatment with indisulam, an anticancer drug that functions through DCAF15 engagement. In AML patients, reduced DCAF15 expression was associated with improved survival. These findings suggest that DCAF15 inhibition may have useful immunomodulatory properties in the treatment of myeloid neoplasms.

引用

页数：31

共 76 条

[31] ESTABLISHMENT AND CHARACTERIZATION OF A HUMAN LEUKEMIC-CELL LINE (SR-91) WITH FEATURES SUGGESTIVE OF EARLY HEMATOPOIETIC PROGENITOR-CELL ORIGIN [J].

KLINGEMANN, HG ;

GONG, HJ ;

MAKI, G ;

HORSMAN, DE ;

DALAL, BI ;

PHILLIPS, GL .

LEUKEMIA & LYMPHOMA, 1994, 12 (5-6) :463-470

[32] Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells [J].

Kroenke, Jan ;

Udeshi, Namrata D. ;

Narla, Anupama ;

Grauman, Peter ;

Hurst, Slater N. ;

McConkey, Marie ;

Svinkina, Tanya ;

Heckl, Dirk ;

Comer, Eamon ;

Li, Xiaoyu ;

Ciarlo, Christie ;

Hartman, Emily ;

Munshi, Nikhil ;

Schenone, Monica ;

Schreiber, Stuart L. ;

Carr, Steven A. ;

Ebert, Benjamin L. .

SCIENCE, 2014, 343 (6168) :301-305

[33] Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia [J].

Ley, Timothy J. ;

Miller, Christopher ;

Ding, Li ;

Raphael, Benjamin J. ;

Mungall, Andrew J. ;

Robertson, A. Gordon ;

Hoadley, Katherine ;

Triche, Timothy J., Jr. ;

Laird, Peter W. ;

Baty, Jack D. ;

Fulton, Lucinda L. ;

Fulton, Robert ;

Heath, Sharon E. ;

Kalicki-Veizer, Joelle ;

Kandoth, Cyriac ;

Klco, Jeffery M. ;

Koboldt, Daniel C. ;

Kanchi, Krishna-Latha ;

Kulkarni, Shashikant ;

Lamprecht, Tamara L. ;

Larson, David E. ;

Lin, Ling ;

Lu, Charles ;

McLellan, Michael D. ;

McMichael, Joshua F. ;

Payton, Jacqueline ;

Schmidt, Heather ;

Spencer, David H. ;

Tomasson, Michael H. ;

Wallis, John W. ;

Wartman, Lukas D. ;

Watson, Mark A. ;

Welch, John ;

Wendl, Michael C. ;

Ally, Adrian ;

Balasundaram, Miruna ;

Birol, Inanc ;

Butterfield, Yaron ;

Chiu, Readman ;

Chu, Andy ;

Chuah, Eric ;

Chun, Hye-Jung ;

Corbett, Richard ;

Dhalla, Noreen ;

Guin, Ranabir ;

He, An ;

Hirst, Carrie ;

Hirst, Martin ;

Holt, Robert A. ;

Jones, Steven .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (22) :2059-2074

[34] MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens [J].

Li, Wei ;

Xu, Han ;

Xiao, Tengfei ;

Cong, Le ;

Love, Michael I. ;

Zhang, Feng ;

Irizarry, Rafael A. ;

Liu, Jun S. ;

Brown, Myles ;

Liu, X. Shirley .

GENOME BIOLOGY, 2014, 15 (12) :554

[35] Induced dendritic cell differentiation of chronic myeloid leukemia blasts is associated with down-regulation of BCR-ABL [J].

Lindner, I ;

Kharfan-Dabaja, MA ;

Ayala, E ;

Kolonias, D ;

Carlson, LM ;

Beazer-Barclay, Y ;

Scherf, U ;

Hnatyszyn, JH ;

Lee, KP .

JOURNAL OF IMMUNOLOGY, 2003, 171 (04) :1780-1791

[36] The Emerging Role of Cohesin in the DNA Damage Response [J].

Litwin, Ireneusz ;

Pilarczyk, Ewa ;

Wysocki, Robert .

GENES, 2018, 9 (12)

[37] Prospects for the use of NK cells in immunotherapy of human cancer [J].

Ljunggren, Hans-Gustaf ;

Malmberg, Karl-Johan .

NATURE REVIEWS IMMUNOLOGY, 2007, 7 (05) :329-339

[38] Control of Metastasis by NK Cells [J].

Lopez-Soto, Alejandro ;

Gonzalez, Segundo ;

Smyth, Mark J. ;

Galluzzi, Lorenzo .

CANCER CELL, 2017, 32 (02) :135-154

[39] The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins [J].

Lu, Gang ;

Middleton, Richard E. ;

Sun, Huahang ;

Naniong, MarkVic ;

Ott, Christopher J. ;

Mitsiades, Constantine S. ;

Wong, Kwok-Kin ;

Bradner, James E. ;

Kaelin, William G., Jr. .

SCIENCE, 2014, 343 (6168) :305-309

[40] Melanoma response to anti-PD-L1 immunotherapy requires JAK1 signaling, but not JAK2 [J].

Luo, Na ;

Formisano, Luigi ;

Gonzalez-Ericsson, Paula I. ;

Sanchez, Violeta ;

Dean, Phillip T. ;

Opalenik, Susan R. ;

Sanders, Melinda E. ;

Cook, Rebecca S. ;

Arteaga, Carlos L. ;

Johnson, Douglas B. ;

Balko, Justin M. .

ONCOIMMUNOLOGY, 2018, 7 (06)

← 1 2 3 4 5 6 7 8 →